Currently out of the existing stock ratings of Jacob Hughes, 14 are a BUY (41.18%), 19 are a HOLD (55.88%), 1 are a SELL (2.94%).

Jacob Hughes

Work Performance Price Targets & Ratings Chart

Analyst Jacob Hughes, currently employed at WELLS FARGO, carries an average stock price target met ratio of 80.56% that have a potential upside of 13.52% achieved within 202 days.

Jacob Hughes’s has documented 67 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on SHW, Sherwin-Williams Co at 15-Dec-2023.

Wall Street Analyst Jacob Hughes

Analyst best performing recommendations are on RVNC (REVANCE THE).
The best stock recommendation documented was for BHC (BAUSCH HEALTH COMPANIES) at 3/23/2020. The price target of $17 was fulfilled within 17 days with a profit of $3.73 (28.11%) receiving and performance score of 16.53.

Average potential price target upside

AMPH Amphastar P BHC Bausch Health Companies JAZZ Jazz Pharmaceuticals PLC MDWD Mediwound Ltd RVNC Revance The IRWD Ironwood Pharmaceuticals KRTX Karuna Therapeutics EBS Emergent Biosolutions SHW Sherwin-Williams Co

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4 months 10 days ago
(08-Aug-2024)

6/6 (100%)

$3.41 (15.79%)

263

Buy

$66

$23.76 (56.25%)

$71

4 months 10 days ago
(08-Aug-2024)

10/13 (76.92%)

$21.94 (49.80%)

337

Buy

$70

$27.76 (65.72%)

$44

1 years 4 months 23 days ago
(25-Jul-2023)

2/3 (66.67%)

$8.35 (13.54%)

105

Hold

$44

$1.76 (4.17%)

$40

1 years 7 months 1 days ago
(17-May-2023)

5/5 (100%)

$1.03 (2.40%)

86

Buy

$33

$-25.16 (-43.26%)

$24

2 years 9 months 7 days ago
(11-Mar-2022)

3/3 (100%)

$-1.3 (-3.79%)

375

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jacob Hughes?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?